AMPLIFY Trademark

Trademark Overview

On Friday, December 18, 2020, a trademark application was filed for AMPLIFY with the United States Patent and Trademark Office. The USPTO has given the AMPLIFY trademark a serial number of 90392528. The federal status of this trademark filing is REGISTERED as of Tuesday, June 13, 2023. This trademark is owned by Decibel Therapeutics, Inc.. The AMPLIFY trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Genetic testing for medical purposes for the testing of hearing loss and balance disorders; none of the foregoing relating to cancer, auto-immune conditions, infectious diseases, or the immune repertoire
amplify

General Information

Serial Number90392528
Word MarkAMPLIFY
Filing DateFriday, December 18, 2020
Status700 - REGISTERED
Status DateTuesday, June 13, 2023
Registration Number7081231
Registration DateTuesday, June 13, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 15, 2022

Trademark Statements

Goods and ServicesGenetic testing for medical purposes for the testing of hearing loss and balance disorders; none of the foregoing relating to cancer, auto-immune conditions, infectious diseases, or the immune repertoire

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 1, 2021
Primary Code044
First Use Anywhere DateSaturday, December 31, 2022
First Use In Commerce DateSaturday, December 31, 2022

Trademark Owner History

Party NameDecibel Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02215
Party NameDecibel Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02215
Party NameDecibel Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02215

Trademark Events

Event DateEvent Description
Friday, December 15, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 15, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 15, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 15, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 15, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 13, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 13, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, May 11, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, May 10, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 11, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 22, 2023USE AMENDMENT FILED
Monday, April 10, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 22, 2023TEAS STATEMENT OF USE RECEIVED
Friday, October 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 12, 2022SOU EXTENSION 1 GRANTED
Wednesday, October 12, 2022SOU EXTENSION 1 FILED
Wednesday, October 12, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, April 12, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 15, 2022PUBLISHED FOR OPPOSITION
Wednesday, January 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 13, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 16, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 16, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 16, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 16, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 16, 2021NON-FINAL ACTION E-MAILED
Wednesday, June 16, 2021NON-FINAL ACTION WRITTEN
Monday, June 14, 2021ASSIGNED TO EXAMINER
Monday, March 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 22, 2020NEW APPLICATION ENTERED

Related Keywords

amplify immune testing auto cancer conditions infectious repertoire diseases relating none